VOGLISUG-GM 3
MRP: 1,485
Packaging: 10x10
Pack Type: tablet
Composition:
Voglibose 0.3mg + Glimepiride 2mg+ Metformin HCI 500mg
Indication:
Lowers post-prandial blood glucose levels in type II diabetics, Prevents sudden surge of glucose after meals, Reduces progression of IGT* to Diabetes.
Description:
Voglibose 0.3mg + Glimepiride 2mg + Metformin Hydrochloride 500mg is a powerful triple-drug oral antidiabetic combination used to manage type 2 diabetes mellitus, especially in patients who require multiple mechanisms to control blood glucose effectively.
Voglibose (0.3mg): An alpha-glucosidase inhibitor that delays carbohydrate breakdown in the intestine, reducing postprandial (after-meal) blood glucose spikes.
Glimepiride (2mg): A sulfonylurea that stimulates the pancreas to release insulin.
Metformin HCl (500mg): A biguanide that lowers hepatic glucose output and enhances insulin sensitivity.
This combination provides comprehensive glycemic control, targeting fasting, post-meal, and baseline glucose levels in one convenient formulation.
Tags:
- Comprehensive glucose control: Fasting, post-meal, and baseline
- Reduces HbA1c effectively
- Convenient once-daily dosage
- Helps reduce glucose variability
- Suitable for patients uncontrolled on dual therapy
- Reduces need for insulin in some cases
- Improves insulin sensitivity and secretion
Usage Information
Dosage
Standard Dosage: One tablet once daily, preferably with breakfast or first main meal Route: Oral Do not skip meals while on this medication Follow your doctor’s prescription and glucose monitoring schedule
Side Effects
Hypoglycemia (low blood sugar) Nausea or vomiting Flatulence and bloating Diarrhea Abdominal discomfort Headache Rare: Allergic reactions or lactic acidosis (due to Metformin)
Contraindications
Hypersensitivity to any ingredient Type 1 diabetes or diabetic ketoacidosis Severe liver or kidney dysfunction Gastrointestinal obstruction (for Voglibose) History of lactic acidosis Pregnancy or breastfeeding (unless specifically advised) Alcohol abuse or conditions predisposing to hypoglycemia
Availability
Voglibose 0.3mg Glimepiride 2mg Metformin 500mg tablet Triple combination for type 2 diabetes Sugar control after meals and fasting Diabetes medicine with Metformin Glimepiride Voglibose Oral antidiabetic triple therapy Type 2 diabetes management tablet Best tablet for postprandial glucose control Glimepiride 2mg combination uses Triple oral diabetic drug benefits Comprehensive glucose control medicine